Trial Profile
An Open-Lable Multicenter Prospective Non-Randomized Trial to Assess the Efficacy and Safety of Morinidazole With Levofloxacin and Sequential of Levofloxacin in Women With Pelvic Inflammatory Disease
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Morinidazole (Primary) ; Levofloxacin; Sodium chloride
- Indications Bacterial infections
- Focus Therapeutic Use
- Sponsors Jiangsu Hansoh Pharmaceutical
- 08 Jan 2018 New trial record